Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
New Wound Healing Breakthrough With Ovine Nano-Collagen QBx™ Integration July 31, 2025- Las Vegas, NV- Regenerex Pharma, Inc (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced the development of new product formulations designed to accelerate deep tissue regeneration through enhanced scaffolding facilitation and cell proliferation. Building on its […]
Regenerex Pharma, Inc. Corporate and Management Structure Update
2024 Growth Strategy and Product Launch to Reset the Wound Bed Space and Accelerate the Healing Process in Chronic Wounds with 95% Success Rate Sept 28, 2023- Las Vegas, NV- Regenerex Pharma, Inc (OTC: RGPX), announces the establishment of its comprehensive management team and the commencement of the Company manufacturing plans in Q4 2023. Regenerex […]
